Skip to content

Author

N. Nortjé

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Systemic anticancer therapy near the end of life and acute health care utilization: A target trial emulation study using SEER–Medicare.

612 Background: Use of Systemic anticancer therapy (SACT) at end-of-life (EOL) has been associated with higher costs, increased hospitalizations (HL), emergency department (ED), and intensive care unit (ICU) utilization and lower hospice (HP) use all of which may adversely affect quality of life. Prior studies...

Maureen E. Canavan, Lee Cheng, Jian-Gong Niu et al. · 0 citations
Open access Oct 2026

Impact of a novel advanced support unit on intensive care unit mortality at a comprehensive cancer center.

573 Background: Many patients with advanced cancer die shortly after an intensive care unit (ICU) admission. For these patients, aggressive critical care may offer limited benefit, may not align with patients’ goals, and may prolong suffering. ICU admissions near the end of life (EOL) may be related to prognost...

J. Botdorf, David Hui, N. Walton et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.